Brief: Shanghai Haohai Biological Technology FY Profit Attributable RMB420.45 Million
21/03/2025 13:42
March 21 (Reuters) - Shanghai Haohai Biological Technology Co Ltd 688366.SS: FY GROSS MARGIN 69.74% FY BASIC EPS RMB 1.8 FINAL DIVIDEND OF RMB0.60 PER SHARE FY REVENUE RMB2.68 BILLION FY PROFIT ATTRIBUTABLE RMB420.45 MILLION Further company coverage: 688366.SS ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Shanghai Haohai Biological Technology
See all newsChina's Haohai Biological H1 revenue falls, partly hurt by end of Brighten Optix distribution
Brief: Shanghai Haohai Biological Technology Says Resignation Of Hou Yongtai As Exec Director, Chair
Brief: Shanghai Haohai Biological Technology Updates On Investigation Of Jiang Wei's Suspected Insider Trading Case
Brief: Shanghai Haohai Biological Technology Proposes To Elect Tian Min As An Additional Executive Director
Brief: Shanghai Haohai Biological Technology Posts Qtrly Net profit Attributable Of RMB73.6 Mln.